Jci_page_head_homepage_01 Jci_page_head_homepage_02
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
Published in Volume 116, Issue 12
J Clin Invest. 2006; 116(12):3258–3265 doi:10.1172/JCI29602
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
Reduced proliferation of CFSE-labeled IGRP206–214-specific CD8+ T cells in NOD-PI mice.

CFSE-labeled CD8+ T cells isolated from NOD8.3 TCR transgenic mice were injected (4–6 × 106 cells/mouse) intravenously into NOD and NOD-PI mice of different ages. Cells were isolated from PLN and ILN 3 days later and analyzed for CFSE dilution by flow cytometry. (A) Percentage (mean ± SEM) of transferred cells dividing in NOD and NOD-PI mice (n = 4–10 mice per group at each time point). P < 0.004, NOD versus NOD-PI in PLN at 6 weeks; P < 0.0002, NOD versus NOD-PI in PLN at 8 weeks; P < 0.01, NOD versus NOD-PI in PLN at 12 weeks. (B) Representative histogram plot. The numbers within the histogram plots indicate percentages of CFSE-low cells.